Upload
mbbs-ims-msu
View
1.127
Download
0
Embed Size (px)
Citation preview
Medical Microbiology Dr. Saleh M.Y. Phase II – MBBS Medical Students
Medical Microbiology
Dr. Saleh M.Y.
Tuesday; 12/10/2010
Bacteriology
Review and Overview
Gram +ve cocci:
(1) Streptococci,
(2) Staphylococci,
(3) Sites of infection
(4) Toxins,
(5) Pathogenicity,
(6) Diagnosis (clinical and laboratory diagnosis) and
(7) Treatment
Definitions: additional to the previous words; define: Acute, Chronic, severe
Streptococcus
Organism:
Genus: Streptococcus, Enterococcus
Species: S. pyogenes (Group A), S. agalactiae (Group B), S. mutans (viridans), S.
pneumoniae, E. faecalis (Group D)
General Concepts:
The streptococci are a very heterogeneous group of bacteria. Some members are a
part of our normal flora while others are potent pathogens.
The primary pathogens are S. pyogenes and S. pneumoniae but other species can be
opportunistic.
1
Group B streptococcus (S.agalactiae)Neonatal septicemia/meningitis CAMP testHippurate hydrolysis testGroup D streptococcusUrinary tract infection/ endocarditis Bile-esculin testEnterococci Non-enterococciLarge colonyMinute colony Viridans streptococciDental caries/endocarditis
Group A streptococcus (S. pyogenes)Lancefield groupsHemolysis (alpha, beta, gamma)Bacitracin susceptibility test M, T, R proteinsStreptolysins O and SF protein/lipoteichoic acidRheumatic fever/carditis/arthritisGlomerulonephritisScarlet feverToxic shock-like syndrome/bacteremia“Flesh-eating bacteria”Pyrogenic toxinErythrogenic toxin
Medical Microbiology Dr. Saleh M.Y. Phase II – MBBS Medical Students
Streptococcus pneumoniae and its infection site
2
Medical Microbiology Dr. Saleh M.Y. Phase II – MBBS Medical Students
Streptococcus pyogenes and its infection site
For example:
1. S. agalactiae can produce severe neonatal disease including:
meningitis, pneumonia and bacteremia in infants aged 7 days up to 3 months
2. S. faecalis (E. faecalis) may be implicated in endocarditis and urinary tract
infections.
3. S. mutans is an important contributor to dental caries.
3
Medical Microbiology Dr. Saleh M.Y. Phase II – MBBS Medical Students
The streptococci are generally delineated into groups according to the Lancefield
method.
As important as the acute diseases produced by these microorganisms are the later
sequelae of Group A streptococci. These sequelae include i) rheumatic fever
following respiratory infections and ii) glomerulonephritis following skin infections.
4
Medical Microbiology Dr. Saleh M.Y. Phase II – MBBS Medical Students
Distinctive Properties:
Streptococci are Gram-positive, non-motile cocci that divide in one plane, producing
chains of cells. S. pneumoniae is a lancet-shaped diplococcus (formerly genus
Diplococcus).
The streptococci are catalase negative (unlike Staphylococcus) and may be either
facultative or obligate anaerobes.
Hemolysis (alpha, beta) on blood agar is an important differential characteristic.
Lancefield groupings are based on the serology of cell wall polysaccharides (18
groups were originally established by Rebecca Lancefield).
The M proteins of group A serve as important virulence factors that help the organism
resist phagocytosis.
Lipoteichoic acids (LTA) mediate attachment to epithelial cells.
Many antigenic moieties on the streptococcal cell surface resemble human muscle
and connective tissue and these similarities may be responsible for the late sequelae.
For example, S. pyogenes membrane Ags resemble cardiac, skeletal, smooth muscle,
heart valve fibroblasts and neuronal tissue.
The capsule of S. pyogenes is composed of hyaluronic acid (like host connective
tissue) so it is non-antigenic while the capsule of S. pneumoniae is very antigenic and
is its sole virulence factor.
Toxins produced by streptococci include: streptolysins (S & O), NADase,
hyaluronidase, streptokinase, DNAses, erythrogenic toxin (causes scarlet fever rash
by producing damage to blood vessels; requires cell to be lysogenized by phage that
encodes toxin).
5
Medical Microbiology Dr. Saleh M.Y. Phase II – MBBS Medical Students
Pathogenesis:
S. pyogenes is the leading cause of bacterial pharyngitis and tonsillitis. It may also
produce sinusitis, otitis, arthritis and bone infections. Some strains prefer skin,
producing either superficial (impetigo) or deep (cellulitis) infections.
S. pneumoniae is the major cause of bacterial pneumonia in adults. Its virulence is
dictated by its capsule.
Post-infection sequelae of S. pyogenes occur 1-3 weeks after acute disease. These
sequelae include i) acute rheumatic fever (following pharyngeal infections) and ii)
glomerulonephritis (following either pharyngeal or skin infections). These sequelae
may be due to an altered immune response (autoantibodies). Glomerulonephritis
results from deposition of Ag:Ab complexes on basement membrane of kidney
glomeruli.
Other species/groups include:
Group B strep (e.g. S. agalactiae) most often produce disease in animals but
are also the leading cause of neonatal septicemia and meningitis.
Group D strep (e.g. E. faecalis) produce urinary tract infections and
endocarditis.
Viridans species (e.g. S. mutans) are responsible for oral caries and subacute
bacterial endocarditis following dental surgery.
Anaerobic streptococci may cause genital, brain or abdominal infections.
6
Medical Microbiology Dr. Saleh M.Y. Phase II – MBBS Medical Students
Host Defenses:
The normal host resists streptococcal infection; they are often secondary invaders.
The capsule of S. pyogenes is poorly immunogenic; anti-M protein Abs are important
in host defense.
The capsule of S. pneumoniae is very immunogenic; anti-capsule Abs are opsonizing,
enhancing phagocytosis.
Pneumococcal infections occur most often in debilitated persons (alcoholics, elderly,
those with underlying disease).
Epidemiology:
These organisms are widely distributed in nature.
Five to 15% of normal healthy individuals carry S. pyogenes.
Carriage of S. pneumoniae (a solely human organism) is age dependent:
Age % Carriage
Less than 5 40%
5 to 9 30%
10 to 15 17%
adults 6%
adults with children 25%
Streptococci are labile organisms that require close personal contact for
transmission; S. pyogenes respiratory disease peaks at 6 and 13 years old, showing
a seasonal pattern (late winter, early spring).
7
Medical Microbiology Dr. Saleh M.Y. Phase II – MBBS Medical Students
Diagnosis:
Clinical: Diagnosis based solely upon symptomology is often not possible.
Laboratory: To confirm the presense of S. pyogenes, throat swabs are used. For S.
pneumoniae, sputum or blood samples are taken. The specimens may then be plated
on blood agar for isolation of Gram-positive, catalase-negative cocci. Useful
characteristics for differentiation include the pattern of hemolysis, bacitracin
resistance or sensitivity and optochin resistance or sensitivity. Immunologically-based
rapid test kits are often employed.
Control:
Sanitary: Since Streptococcus is a labile organism, close contact is required for
spread; hence, avoiding contagious contacts can prevent disease.
Immunological: Pneumococcal vaccines are available for persons at high risk,
particularly the elderly.
Chemotherapeutic: Penicillin is the drug of choice for S. pyogenes and S.
pneumoniae, when the organisms are susceptible. Chemotherapy is given over a 10
and 7-145 days regimen, respectively. Group D streptococci are resistant to many
antibiotics. Life long prophylaxis (low dose penicillin) is recommended for rheumatic
fever patients.
8